Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BSofiva Genomics 〉Prenatal diagnosis by Oligonucleotide array-comparative genomic hybridization analysis test

Prenatal diagnosis by Oligonucleotide array-comparative genomic hybridization analysis test

Prenatal diagnosis by Oligonucleotide array-comparative genomic hybridization analysis test

1. Comply with International standard cell gene chip Alliance (ISCA) standards.2. Provide fast, high accuracy and high resolution by using Oligo Array.3. Build database more than 15,000 people in Taiwan.

Request for Collaboration
Overview
Oligonucleotide array-comparative genomic hybridization analysis test (CGH) is the most powerful and progressive genome technique that allows the detection of losses and gains in chromosome copy number across the entire genome without prior knowledge of specific chromosomal abnormalities. With the more specific probes which are to detect the position of a specific gene, the more subtle changes in genetic material can be seen. With a known standard sample fluorescence of different colors, respectively, designed in the wafer after the reaction with different fluorescence intensities to determine the increase or decrease in the gene and then get results by the comparison of distinction. Array CGH technology provides more comprehensive, accurate and fast alternative for prenatal diagnosis of chromosome disease.
Application
I. Expectant mother / prenatal check
1. Who aged above 34.
2. Who wants to reduce the risk of pregnancy.
3. Who wants to get further diagnosis after knowing abnormality of traditional chromosome and fetal ultrasound.
4. Who has a family history of congenital abnormalities or conceives congenital anomalies baby.
II. Newborn / postnatal check
1. Who has multiple congenital anomalies
2. Who has developmental delay
3. Who has mental retardation
4. Who has abnormal appearance
More Information
People who like this also like
  • PixoTest technologyPixoTest technology
  • State-of-the-art FacilityState-of-the-art Facility
  • PeptidePeptide
  • Stabilized Injectable Formulation - SIFStabilized Injectable Formulation - SIF
  • CHAP™CHAP™
  • TLC399TLC399
  • Patented CMx® PlatformPatented CMx® Platform
  • Dynamic Auto-FocusingDynamic Auto-Focusing
  • RNTA06RNTA06
  • LT1001LT1001